NVO

Novo Nordisk ADR

Sep 17 • 11:11AM ET

58.72

+1.52 2.67 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: AVDE PPH WCMI PID RVER DFIC APIE OZEM PVAL DIVZ

Index	-	P/E	16.18	EPS (ttm)	3.63	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	8.01%
Market Cap	197.68B	Forward P/E	14.16	EPS next Y	4.15	Insider Trans	-	Shs Float	3.37B	Perf Month	9.26%
Enterprise Value	210.32B	PEG	1.29	EPS next Q	0.86	Inst Own	9.36%	Short Float	0.77%	Perf Quarter	-21.00%
Income	16.18B	P/S	4.35	EPS this Y	21.24%	Inst Trans	-5.67%	Short Ratio	1.60	Perf Half Y	-27.48%
Sales	45.45B	P/B	9.86	EPS next Y	8.18%	ROA	25.10%	Short Interest	25.78M	Perf YTD	-31.73%
Book/sh	5.95	P/C	66.36	EPS next 5Y	12.58%	ROE	75.95%	52W High	135.20 -56.56%	Perf Year	-57.14%
Cash/sh	0.88	P/FCF	20.83	EPS past 3/5Y	25.78% 21.74%	ROIC	40.28%	52W Low	45.05 30.36%	Perf 3Y	7.43%
Dividend Est.	1.88 (3.20%)	EV/EBITDA	8.99	Sales past 3/5Y	23.46% 18.15%	Gross Margin	83.94%	Volatility	2.13% 2.13%	Perf 5Y	78.44%
Dividend TTM	1.73 (2.94%)	EV/Sales	4.63	EPS Y/Y TTM	24.50%	Oper. Margin	46.36%	ATR (14)	1.67	Perf 10Y	110.52%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.56	Sales Y/Y TTM	21.52%	Profit Margin	35.60%	RSI (14)	61.20	Recom	2.03
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	39.83%	SMA20	5.28%	Beta	0.69	Target Price	70.74
Payout	35.93%	Debt/Eq	0.59	Sales Q/Q	18.96%	SMA50	2.16%	Rel Volume	1.71	Prev Close	57.20
Employees	76302	LT Debt/Eq	0.52	Earnings	Aug 06 BMO	SMA200	-20.29%	Avg Volume	16.15M	Price	58.72
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.32% 0.71%	Trades		Volume	8,167,440	Change	2.67%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-15-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

Show Previous Ratings

Today 10:44AM	Lyft & Waymo, Eli Lilly, Opendoor: Trending Tickers (Yahoo Finance Video)
09:53AM	NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity (Zacks)
05:16AM	2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now (Motley Fool)
Sep-16-25 05:33PM	Why Novo Nordisk Stock Popped Today (Motley Fool)
04:14PM	FDA Slams Hims & Hers With A Warning Letter. Investors Slam Hims Stock. (Investor's Business Daily)
12:58PM	Loading…
12:58PM	AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play? (Zacks)
12:15PM	Novo Nordisk A/S (NVO): A Bull Case Theory (Insider Monkey)
12:09PM	Oracle & TikTok, Amazon's next Prime Day, Novo trial results (Yahoo Finance Video)
10:51AM	Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD? (Zacks)
08:54AM	Will Rybelsus' Updated EU Label Propel Fresh Growth Potential for NVO? (Zacks)
07:01AM	Novo Nordisks Wegovy may quiet thoughts about food, study shows; shares up (Investing.com)
06:27AM	Jim Cramer Discusses Novo Nordisk A/S (NVO) And CVS (Insider Monkey)
03:15AM	Here Is My Top Stock Pick Among the Weight Loss Industry Leaders (Motley Fool)
Sep-15-25 01:22PM	Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact (Benzinga)
12:26PM	Hims & Hers Is in the FDA's Crosshairs. It's a Risk to the Stock. (Barrons.com)
11:34AM	Loading…
11:34AM	Why Novo Nordisk Stock Popped Today (Motley Fool)
11:08AM	Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now? (Zacks)
10:50AM	Novo Nordisk Stock Rises. Its Diabetes Pill Cleared a Key Hurdle. (Barrons.com)
08:44AM	Novo Nordisk Shares Rise as Obesity Trial Results Narrow Gap With Eli Lilly (GuruFocus.com)
08:15AM	Novo Nordisk (NVO) Announces a Major Company Wide Transformation (Insider Monkey)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
05:45PM	Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note (Zacks)
12:56PM	GLP-1 obesity pills face off in head-to-head trial (CNBC TV)
12:11PM	Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. (Barrons.com)
Sep-11-25 03:43PM	Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback (Motley Fool)
10:02AM	Where Does VKTX Stock Stand After the Obesity Pill Setback? (Zacks)
10:01AM	Prothena Down 40% Year to Date: What Lies Ahead for the Stock? (Zacks)
04:59AM	2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades (Motley Fool)
Sep-10-25 04:05PM	Novo Nordisk Tightens Its Belt, Cutting 9,000 Jobs And Its Profit Outlook (Investor's Business Daily)
02:59PM	Novo Nordisk Stock Rises as Investors Cheer 9,000 Job Cuts Despite Guidance Cut (GuruFocus.com)
02:49PM	Loading…
02:49PM	Novo Nordisk to cut 9,000 jobs (CNBC TV)
02:29PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
01:24PM	Novo Just Fired 9,000 People--And Investors Are Buying the Dip (GuruFocus.com)
11:06AM	NVS to Acquire TRML, Add Phase III Cardiovascular Drug to Pipeline (Zacks)
10:54AM	Ozempic Parent Announces 9,000 Job Cuts in Restructuring Plan (Schaeffer's Research)
10:28AM	Is NVO's Major Restructuring Plan an Indication to Sell the Stock? (Zacks)
10:20AM	Ozempic maker Novo Nordisk to cut 9,000 jobs amid stiff weight-loss drug competition (Quartz)
09:34AM	Synopsys China slowdown, Novo Nordisk job cuts, Chewy earnings (Yahoo Finance Video)
06:32AM	Novo Nordisk Cuts 9,000 Jobs and Slashes Guidance. Why the Stock Is Rising. (Barrons.com)
04:47AM	Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs - and its profit forecast (MarketWatch)
01:07AM	Wegovy-maker Novo Nordisk to slash 9,000 jobs as competition intensifies (Reuters)
Sep-09-25 04:06PM	Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense' (Investor's Business Daily)
09:00AM	Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:10AM	Novonesis and Novo Nordisk collaborate on gut microbiome research initiative (Pharmaceutical Business Review)
Sep-08-25 09:00PM	1 Reason Every Investor Should Know About Novo Nordisk (NVO) (Motley Fool)
Sep-05-25 08:45AM	Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO (PR Newswire)
07:46AM	Weight loss has become the hottest new Chinese consumer craze (MarketWatch)
06:00AM	Why weight-loss 'wonder drugs' aren't 'wonder stocks' yet (Yahoo Finance)
04:10AM	Down 34%, Should You Buy the Dip on Viking Therapeutics? (Motley Fool)
Sep-04-25 10:30AM	TEVA Stock Up More Than 19% in a Month: Buy, Sell or Hold the Stock? (Zacks)
Sep-03-25 01:48PM	The Problem With Weight Loss Stocks (Motley Fool)
01:19PM	Hims & Hers gains after court rejects Eli Lillys case against Willow (Investing.com)
09:00AM	Should You Buy Novo Nordisk Stock Now or Wait? (Motley Fool)
05:07AM	Is Novo Nordisk Stock a Buy Now? (Motley Fool)
Sep-02-25 11:13AM	UBS Maintains a Hold on Novo Nordisk (NVO) (Insider Monkey)
10:30AM	Viking Therapeutics Loses 20% in a Month: How to Play the Stock (Zacks)
09:48AM	GSK Adds Around $5B in a Month: Here's How to Play the Stock (Zacks)
09:36AM	Constellation Brands, Novo Nordisk, Klarna IPO: Trending Tickers (Yahoo Finance Video)
09:27AM	What Makes Novo Nordisk A/S (NVO) an Attractive Investment Compared to Competitors? (Insider Monkey)
09:05AM	Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death (Benzinga)
04:04AM	Novo Nordisk A/S (NVO) Wins U.S. Wegovy Approval for MASH, Expands to China Market (Insider Monkey)
Sep-01-25 11:59AM	Pfizer's Golden Cross Signals Strength: How to Play the Stock (Zacks)
10:54AM	NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction? (Zacks)
08:55AM	Novo Nordisk (NVO) Jumps as Wegovy Beats Eli Lilly in Cardiovascular Outcomes (GuruFocus.com)
06:39AM	Novo's Wegovy Beats Lilly's Zepbound for Heart Health, Study Finds. What It Means for Stocks. (Barrons.com)
Aug-31-25 02:11AM	Novo Nordisk (NVO) Gains Momentum With Strong Earnings and Wegovy FDA Approval (Insider Monkey)
Aug-28-25 04:09PM	FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk (Investor's Business Daily)
08:00AM	Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure (Investor's Business Daily)
04:29AM	2 Dividend Stocks to Hold for the Next 10 Years (Motley Fool)
03:26AM	2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade (Motley Fool)
Aug-27-25 10:52AM	Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet? (Zacks)
08:11AM	Does Lilly's New Obesity Pill Data Put It Back in the Weight Game? (Zacks)
08:08AM	LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors? (Zacks)
Aug-26-25 11:53PM	Novo Nordisk Recieves an Upgrade From DBS, Price Cut From TD Cowen (Insider Monkey)
06:23PM	Why Novo Nordisk Stock Tumbled on Tuesday (Motley Fool)
05:21PM	Eli Lillys weight-loss pill meets target in key diabetes trial (Financial Times)
04:08PM	Eli Lilly's 'Surprising Development' In Obesity Just Slammed Novo Stock (Investor's Business Daily)
12:07PM	Eli Lilly Stock Rises. Its Pill Has Ramped Up the Weight-Loss War With Novo Nordisk. (Barrons.com)
11:09AM	Can Novo Nordisk Offset GLP-1 Pressures With Rare Disease Wins? (Zacks)
10:55AM	LLY obesity data seen as small sentiment hit for NVO, no major changeBarclays (Investing.com)
09:47AM	Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump (Investor's Business Daily)
08:06AM	AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock? (Zacks)
07:27AM	Eli Lilly Says New Pill Results in 10.5% Weight-Loss for Diabetes Patients. The Stock Is Up. (Barrons.com)
06:50AM	Eli Lilly Says New Pill Results in 10.5% Weight-Loss for Diabetes Patients (Barrons.com)
06:15AM	Viking Therapeutics: What's Next? (Motley Fool)
12:14AM	TD Cowen Lowers PT on Novo Nordisk (NVO), Keeps a Buy (Insider Monkey)
Aug-25-25 01:59PM	FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles (Benzinga)
11:02AM	Here's Why GreensKeeper Asset Management Added Novo Nordisk (NVO) to Its Portfolio (Insider Monkey)
10:57AM	Here's Why Burke Wealth Management Sold Novo Nordisk (NVO) (Insider Monkey)
10:30AM	Did You Lose Money on Novo Nordisk A/S (NVO)? Levi & Korsinsky Urges Investors to Act Before September 30, 2025 (Newsfile)
09:00AM	Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know (Zacks)
Aug-23-25 09:05AM	Cat hair, bacteria found at Novo Nordisk plant during inspection, STAT reports (TipRanks)
Aug-22-25 12:16PM	Stocks surge, Novo Nordisk cuts bonuses, Waymo to test in NYC (Yahoo Finance Video)
08:49AM	Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans? (Zacks)
05:57AM	The Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk (Zacks)
Aug-21-25 05:47PM	Novo Nordisk Just Froze Hiring--and It's Rattling Denmark's Economy (GuruFocus.com)
12:05PM	Post Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock? (Zacks)
11:00AM	Is This the Right Time to Consider Healthcare ETFs? (Zacks)
09:51AM	FDA Extends Review Period of REGN's Submission for Eylea HD (Zacks)
08:45AM	The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know (Motley Fool)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience